New therapies offer promise for cutaneous T-cell lymphoma

Some of the continuing challenges central to the management of cutaneous T-cell lymphoma (CTCL) include improving the survival and prognosis of patients, as well as helping to make proposed treatments more affordable and accessible, says Elise A. Olsen, M.D.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.